D.E. Shaw & Co
ISLE

D.E. Shaw & Co’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

D.E. Shaw & Co’s Portfolio ISLE Stock Details ISLE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,166,751
Closed -$11.6M – 5771
2022
Q2 		$11.6M Hold
1,166,751
– – 0.01% 1264
2022
Q1 		$11.6M Buy
1,166,751
+169,273
+17% +$1.67M 0.01% 1478
2021
Q4 		$9.81M Buy
997,478
+255,233
+34% +$2.51M 0.01% 1683
2021
Q3 		$7.3M Buy
742,245
+475,629
+178% +$4.64M 0.01% 1774
2021
Q2 		$2.61M Buy
+266,616
New +$2.6M ﹤0.01% 2660

D.E. Shaw & Co's ISLE Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 1,166,751 shares — an estimated $11.6M sold.

D.E. Shaw & Co first reported a position in ISLE in Q2 2021 and held it in 5 quarters. The position peaked at $11.6M in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,166,751 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $11.6M.
  • D.E. Shaw & Co first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q2 2021 and held it in 5 quarters.
  • D.E. Shaw & Co's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $11.6M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.